Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history studyAndrew Staron, Vaishali Sanchorawala, Luke Zheng et al.|Blood Cancer Journal|2021Cited by 143
Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparitiesAndrew Staron, Vaishali Sanchorawala, Lawreen H. Connors et al.|Blood Cancer Journal|2020Cited by 43
Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosisK. H. Vincent Lau, Vaishali Sanchorawala, Gheorghe Doros et al.|Amyloid|2023Cited by 4
A 40-Year Natural History Study of Overall Survival and Primary Causes of Death in Systemic Light Chain (AL) AmyloidosisAndrew Staron, Vaishali Sanchorawala, Luke Zheng et al.|Blood|2021Cited by 2
Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian AmericansAndrew Staron, Vaishali Sanchorawala, Luke Zheng et al.|Blood Cancer Journal|2022Cited by 2